These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25174923)

  • 41. Kinetic analyses and inhibition studies reveal novel features in peptide deformylase 1 from Trypanosoma cruzi.
    Rodrígues-Poveda CA; Pérez-Moreno G; Vidal AE; Urbina JA; González-Pacanowska D; Ruiz-Pérez LM
    Mol Biochem Parasitol; 2012; 182(1-2):83-7. PubMed ID: 22209909
    [TBL] [Abstract][Full Text] [Related]  

  • 42. New antibiotic molecules: bypassing the membrane barrier of gram negative bacteria increases the activity of peptide deformylase inhibitors.
    Mamelli L; Petit S; Chevalier J; Giglione C; Lieutaud A; Meinnel T; Artaud I; Pagès JM
    PLoS One; 2009 Jul; 4(7):e6443. PubMed ID: 19649280
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Commercial broth microdilution panel validation and reproducibility trials for NVP PDF-713 (LBM 415), a novel inhibitor of bacterial peptide deformylase.
    Fritsche TR; Moet GJ; Jones RN
    Clin Microbiol Infect; 2004 Sep; 10(9):857-60. PubMed ID: 15355422
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design, synthesis and antibacterial activity of 3-methylenepyrrolidine formyl hydroxyamino derivatives as novel peptide deformylase inhibitors.
    Shi W; Ma H; Duan Y; Aubart K; Fang Y; Zonis R; Yang L; Hu W
    Bioorg Med Chem Lett; 2011 Feb; 21(3):1060-3. PubMed ID: 21185180
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structure-Based Drug Design of Small Molecule Peptide Deformylase Inhibitors to Treat Cancer.
    Gao J; Wang T; Qiu S; Zhu Y; Liang L; Zheng Y
    Molecules; 2016 Mar; 21(4):396. PubMed ID: 27023495
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human mitochondrial peptide deformylase, a new anticancer target of actinonin-based antibiotics.
    Lee MD; She Y; Soskis MJ; Borella CP; Gardner JR; Hayes PA; Dy BM; Heaney ML; Philips MR; Bornmann WG; Sirotnak FM; Scheinberg DA
    J Clin Invest; 2004 Oct; 114(8):1107-16. PubMed ID: 15489958
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Peptide deformylase inhibitors of Mycobacterium tuberculosis: synthesis, structural investigations, and biological results.
    Pichota A; Duraiswamy J; Yin Z; Keller TH; Alam J; Liung S; Lee G; Ding M; Wang G; Chan WL; Schreiber M; Ma I; Beer D; Ngew X; Mukherjee K; Nanjundappa M; Teo JW; Thayalan P; Yap A; Dick T; Meng W; Xu M; Koehn J; Pan SH; Clark K; Xie X; Shoen C; Cynamon M
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6568-72. PubMed ID: 19008098
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High-throughput screening of peptide deformylase inhibitors.
    Nguyen KT; Pei D
    Methods Mol Med; 2008; 142():117-30. PubMed ID: 18437310
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of an eukaryotic peptide deformylase from Plasmodium falciparum.
    Bracchi-Ricard V; Nguyen KT; Zhou Y; Rajagopalan PT; Chakrabarti D; Pei D
    Arch Biochem Biophys; 2001 Dec; 396(2):162-70. PubMed ID: 11747293
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition and structure-activity studies of methionine hydroxamic acid derivatives with bacterial peptide deformylase.
    Grant SK; Green BG; Kozarich JW
    Bioorg Chem; 2001 Aug; 29(4):211-22. PubMed ID: 16256693
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Theoretical study of Escherichia coli peptide deformylase inhibition by several drugs.
    Chikhi A; Bensegueni A; Boulahrouf A; Bencharif M
    In Silico Biol; 2006; 6(5):459-66. PubMed ID: 17274774
    [TBL] [Abstract][Full Text] [Related]  

  • 52. UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC) inhibitors: a new class of antibacterial agents.
    Zhang J; Zhang L; Li X; Xu W
    Curr Med Chem; 2012; 19(13):2038-50. PubMed ID: 22414079
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Understanding the highly efficient catalysis of prokaryotic peptide deformylases by shedding light on the determinants specifying the low activity of the human counterpart.
    Fieulaine S; Desmadril M; Meinnel T; Giglione C
    Acta Crystallogr D Biol Crystallogr; 2014 Feb; 70(Pt 2):242-52. PubMed ID: 24531459
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Isoxazole-3-hydroxamic acid derivatives as peptide deformylase inhibitors and potential antibacterial agents.
    Calí P; Naerum L; Mukhija S; Hjelmencrantz A
    Bioorg Med Chem Lett; 2004 Dec; 14(24):5997-6000. PubMed ID: 15546716
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of novel potent hydroxamic acid inhibitors of peptidyl deformylase and the importance of the hydroxamic acid functionality on inhibition.
    Thorarensen A; Deibel MR; Rohrer DC; Vosters AF; Yem AW; Marshall VD; Lynn JC; Bohanon MJ; Tomich PK; Zurenko GE; Sweeney MT; Jensen RM; Nielsen JW; Seest EP; Dolak LA
    Bioorg Med Chem Lett; 2001 Jun; 11(11):1355-8. PubMed ID: 11378353
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Peptide deformylase--a promising therapeutic target for tuberculosis and antibacterial drug discovery.
    Sharma A; Khuller GK; Sharma S
    Expert Opin Ther Targets; 2009 Jul; 13(7):753-65. PubMed ID: 19530983
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Asymmetric synthesis of BB-3497--a potent peptide deformylase inhibitor.
    Pratt LM; Beckett RP; Davies SJ; Launchbury SB; Miller A; Spavold ZM; Todd RS; Whittaker M
    Bioorg Med Chem Lett; 2001 Oct; 11(19):2585-8. PubMed ID: 11551755
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Potential utility of a peptide deformylase inhibitor (NVP PDF-713) against oxazolidinone-resistant or streptogramin-resistant Gram-positive organism isolates.
    Jones RN; Moet GJ; Sader HS; Fritsche TR
    J Antimicrob Chemother; 2004 May; 53(5):804-7. PubMed ID: 15056649
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Peptide deformylases from Vibrio parahaemolyticus phage and bacteria display similar deformylase activity and inhibitor binding clefts.
    Grzela R; Nusbaum J; Fieulaine S; Lavecchia F; Desmadril M; Nhiri N; Van Dorsselaer A; Cianferani S; Jacquet E; Meinnel T; Giglione C
    Biochim Biophys Acta Proteins Proteom; 2018 Feb; 1866(2):348-355. PubMed ID: 29101077
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of a new peptide deformylase gene from enterococcus faecium and establishment of a new screening model targeted on PDF for novel antibiotics.
    Tang XB; Si SY; Zhang YQ
    Biomed Environ Sci; 2004 Sep; 17(3):350-8. PubMed ID: 15602833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.